Examination of Quorum Sensing Mechanisms in Glioblastoma Multiforme
CSEF · 2013 Pharmacology/ Toxicology Third Award
Overview
Objectives/Goals Glioblastoma multiforme (GBM) is a prevalent and deadly primary brain tumor in humans. It is reported that glycoprotein Prominin 1 (CD133/1) expression is associated with a distinct population of stem/progenitor GBM cells that have increased capacities for self-renewal, sphere formation, and tumor initiation. Quorum sensing (QS) is a cell-signaling mechanism utilized by bacteria to track cell density and coordinate gene expression and population behavior based on said cell density. I hypothesized that a QS mechanism may be used by GBM cells to regulate populations of CD133-expressing cells, and attempted in this study to probe populations of GBM cells for behaviors consistent with a QS mechanism. Methods/Materials Phase I: Patient-derived brain tumor cells (cell line PBT003) were cultured in vitro for several passages, following which fluorescence-activated cell sorting (FACS) was used to separate CD133/1^+ cells from CD133/1^- cells. Cells of the top 5% of each group (selected to ensure purity) were cultured separately for twelve days. Cells were then reanalyzed for CD133/1 expression using flow cytometry. Phase II: PBT003 cells were cultured in the presence or absence of exogenous tumor necrosis factor-alpha (TNF-alpha) for six days, following which their CD133/1 expression was assayed by flow cytometry. Results Phase I: CD133/1^+ and CD133/1^- PBT003 cell populations responded differently to culture: the CD133/1^- population originally isolated by FACS remained almost entirely CD133/1^-, whereas the CD133/1^+ population returned to a ''steady state'' in which the ratio of CD133/1^+ to CD133/1^- cells mirrored that of the original unsorted cultures. Phase II: Preliminary results indicate that TNF-alpha, a putative autoinducer, increases extracellular and intracellular expression of CD133/1 (as compared to cultures without TNF-alpha). Such a change in cell state would be an expected result of the addition of an autoinducer in a QS mechanism. Conclusions/Discussion The reversion of CD133/1^+ cells to a ''steady state'' is consistent with a QS mechanism. TNF-alpha has been shown to increase CD133/1 expression and could possibly be driving populations of GBM cells towards a more disseminatory phenotype. These results are consistent with the hypothesis that TNF-alpha secreted by tumor cells may be functioning as an autoinducer in a QS model of CD133 expression/glioma proliferation.
Summary statement
Glioblastoma multiforme exhibits behaviors consistent with a quorum-sensing mechanism.
Help received
Dr. Michael Barish and Dr. Susan Kane helped me fine-tune my idea; Ms. Nousha Khosh and Mr. Bradley Huss trained me in the use of lab equipment at the City of Hope Beckman Research Institute and supervised me while I conducted my project; parents helped me commute to City of Hope.
Awards (1)
Competition history
- CSEF 2013
Resources
Related projects
CSEF · 2018
The Application of Exosomes for Diagnostics and Prognostics in Brain Tumors: Medulloblastoma and Glioblastoma
ISEF · 2022
Evaluating the Migration of Glioblastoma Stem Cells in vitro Towards a Chemoattractant Gradient
AJAS · 2025
In Vitro Approach to Identify Preclinical Drug Targets to Treat Glioblastoma Multiforme
CSEF · 2006
Human Dendritic Cells as a Clinical Tool to Cure Human Brain Tumors
CSEF · 2015
The Role Model Effect: Optimizing Blood Macrophage Signal Transduction in a Novel Treatment Method for Leukemia
ISEF · 2019
The Effect of Interaction with Neural Stem Cells on the Migration, Proliferation, and Proteome of GBM Cells
ISEF · 2016
Designing a Novel Technique to Determine Patient Suitability for Brain Cancer Clinical Trials
CSEF · 2013
Drug Screening to Identify Novel Therapeutics against Glioblastoma Stem Cells: Year 2
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects